Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial. (Q50122128)
scientific article
Language:
Current Data About Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial.
(P31) (Q13442814)
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P50) (Q64257169)
(P1545) 1
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P304) 263-274
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P407) (Q1860)

(P433) 2
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P478) 64
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P577) Thursday, December 9, 2010
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P921) (Q42824440)

(Q79460)
(P887)

(Q10355321)
(P887)

(P1433) (Q15757046)
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P1476) "Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial" (language: en)
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

(P2093) Kenneth B Gordon
(P1545) 2
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

Richard G Langley
(P1545) 3
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

Alan Menter
(P1545) 4
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

Renee J Perdok
(P1545) 5
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

Joaquin Valdes
(P1545) 6
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

ABT-874 Study Investigators
(P1545) 7
(P248)
(P698) 21145618
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145618%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, January 17, 2020

other details
description scientific article

External Links
(P356) 10.1016/J.JAAD.2010.01.030
(P698) 21145618